Skip to main content

Table 1 Characteristics of Behçet’s disease (BD) patients and healthy controls

From: Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease

Demographics

Active BD

Inactive BD

Healthy control

Age (mean ± SD)

41.86 ± 7.54

43.6 ± 8.04

38.93 ± 6.94

Sex (male:female)

6:9

7:8

7:8

Clinical characteristics of BD patients

Case number (%)

  

 Major symptoms

   

  Oral ulcer

15 (100)

  

  Genital ulcer

10 (67)

  

  Skin lesion

10 (67)

  

  Ocular lesion

4 (27)

  

 Minor symptoms

   

  Arthritis

2 (13)

  

  GI involvement

1 (7)

  

  Epididymitis

0

  

  Cardiovascular

1 (7)

  

  CNS involvement

1 (7)

  

Medication

   

 Immunosuppressive agenta

6 (40)

0 (0)

 

 Anti-inflammatory drugsb

9 (60)

7 (46)

 
  1. aMethylprednisolone 8–24 mg/d
  2. bColchicine 1.2 mg/d ± minocycline 100 mg/d ± pentoxiphylline 800 mg/d ± sulfasalazine 1000 mg/d